Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...

The new liquid formulation of Rotarix does not require reconstitution or dilution before use. The Food and Drug Administration (FDA) has approved an oral-dosing applicator-only presentation (liquid ...

Artificial intelligence is redefining how fire tests are used in polyurethane foam R&D, delivering faster insights and ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Alchemite ™ advanced machine learning was used by Domino Printing Sciences to leverage historical data and obtain several novel ink formulations, a number of which were later validated via physical ...

Occasionally referred to as ‘colloidal gold,’ gold colloid is a suspension comprising sub-micron gold nanoparticles suspended in a solvent - most commonly water. Gold nanoparticles' distinct ...

Formulation 4.1 continues the story of bringing digital to all aspect of formulation and looks at how Industry 4.0 is changing the formulation industry. The meeting will showcase ongoing activities ...